BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26248421)

  • 1. [Effects of midazolam on hERG K+ channel].
    Han SN; Wang P; Zhang W; Zhang LR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Mar; 31(2):143-7. PubMed ID: 26248421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
    Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
    Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
    Han S; Zhang Y; Chen Q; Duan Y; Zheng T; Hu X; Zhang Z; Zhang L
    Eur J Pharmacol; 2011 Jan; 650(1):138-44. PubMed ID: 20951697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol inhibits hERG K
    Han SN; Jing Y; Yang LL; Zhang Z; Zhang LR
    Eur J Pharmacol; 2016 Nov; 791():168-178. PubMed ID: 27575519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
    Park SJ; Kim KS; Kim EJ
    J Appl Toxicol; 2008 Mar; 28(2):104-11. PubMed ID: 17516459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
    Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
    Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
    Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
    J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block effect of capsaicin on hERG potassium currents is enhanced by S6 mutation at Y652.
    Xing J; Ma J; Zhang P; Fan X
    Eur J Pharmacol; 2010 Mar; 630(1-3):1-9. PubMed ID: 19903464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels.
    Tang Q; Li ZQ; Li W; Guo J; Sun HY; Zhang XH; Lau CP; Tse HF; Zhang S; Li GR
    Br J Pharmacol; 2008 Oct; 155(3):365-73. PubMed ID: 18574455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
    Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
    Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
    Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
    J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel.
    Su Z; Martin R; Cox BF; Gintant G
    J Mol Cell Cardiol; 2004 Jan; 36(1):151-60. PubMed ID: 14734057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
    Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
    Kawakami K; Nagatomo T; Abe H; Kikuchi K; Takemasa H; Anson BD; Delisle BP; January CT; Nakashima Y
    Br J Pharmacol; 2006 Mar; 147(6):642-52. PubMed ID: 16314852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate.
    Dong Q; Fu XX; Du LL; Zhao N; Xia CK; Yu KW; Cheng LX; Du YM
    Biol Pharm Bull; 2013; 36(2):268-75. PubMed ID: 23196655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.
    Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H
    Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
    Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HERG channels by the local anaesthetic articaine.
    Siebrands CC; Friederich P
    Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
    Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN
    Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.